載入...
Meta-Analysis of the Safety and Efficacy of the Oral Anticoagulant Agents (Apixaban, Rivaroxaban, Dabigatran) in Patients With Acute Coronary Syndrome
The significance of adding new oral anticoagulants (NOACs) to antiplatelet therapy in patients with acute coronary syndrome (ACS) is unclear. We conducted a meta-analysis to assess the safety and efficacy of adding NOACs (apixaban, rivaroxaban, and dabigatran) to single antiplatelet agent (SAP) or d...
Na minha lista:
| 發表在: | Am J Cardiol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7453967/ https://ncbi.nlm.nih.gov/pubmed/29195825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.10.035 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|